Meeting
2016 Gastrointestinal Cancers Symposium
Efficacy of chemotherapy in patients with pancreatic acinar cell carcinoma.
Authors
Changhoon Yoo
Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
Changhoon Yoo , Bumjun Kim , Kyu-Pyo Kim , Jae-Lyun Lee , Tae Won Kim , Baek-Yeol Ryoo , Heung-Moon Chang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 308)
DOI
10.1200/jco.2016.34.4_suppl.308
Abstract #
308
Poster Bd #
F10
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
GEMINI-Gastric: A phase 2 study of novel treatment combinations in patients with locally advanced unresectable or metastatic gastric cancers.
First Author: Lin Shen
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Anlotinib combined with penpulimab and hepatic artery infusion chemotherapy (HAIC) in the first-line treatment of unresectable hepatocellular carcinoma.
First Author: Gong-Rang Chen
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and tislelizumab for unresectable hepatocellular carcinoma: A single-arm, phase II study.
First Author: Yongkang Xu
Poster
2023 ASCO Annual Meeting
STAR-221: A randomized, open-label, multicenter, phase 3 trial of domvanalimab, zimberelimab, and chemotherapy versus nivolumab and chemotherapy in previously untreated, locally advanced, unresectable or metastatic gastric, gastroesophageal junction, and esophageal adenocarcinoma.
First Author: Samuel J Klempner